Oriza Seed Venture Capital is a professional early-stage equity investment platform of Oriza Holdings, based in Suzhou Industrial Park, China. It focuses on investing in early-stage and growth-stage start-ups in the healthcare, TMT, intelligent manufacturing, big data, AI, and IC sectors.
They made 2 investments in the last 12 months. Their most common stage is series-a (58% of deals). Average disclosed round size is $59.2M (across 5 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Jianjiang Fei
General Manager, Managing Partner
Aiying Yang
Guangzhou Regional Partner
Bing Zhu
NanTong Regional Partner
Di Wu
Partner,COO
Ding Zheng
Hangzhou Regional Partner
Fei Mi
Beijing Regional Partner
Jinxin Le
TMT Partner
Min Du
Suzhou Regional Partner
Mingda Jiang
TMT Partner
Qun Zhao
Healthcare Partner
Wenlong Sun
Venture Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Stairmed | Growth | — | Apr 2026 |
 Xense Robotics | Series A | — | Oct 2025 |
| Xense Robotics | Series A | — | Jan 2025 |
| EEccogene | Series B | — | Jun 2023 |
| EEccogene | Series B | — | Jan 2023 |
 Rootpath | Series A | — | Jan 2020 |
| AAscentage Pharma | Series C | $150M | Jul 2018 |
 JW Therapeutics | Series A | $90M | Mar 2018 |
| AAscentage Pharma | Series A | $15.5M | Aug 2015 |
| AAscentage Pharma | Series A | $15.5M | Jan 2015 |
| Xense Robotics | Seed | — | — |
 EpimAb Biotherapeutics | Series A | $25M | — |
Top Co-Investors
Last updated: 19 September 2026